Ischaemic burden and changes in absolute myocardial perfusion after chronic total occlusion percutaneous coronary

Stefan P Schumacher1, Marly Kockx, Wijnand J Stuijfzand

  • 1Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Insights

Chronic total occlusion percutaneous coronary intervention (CTO PCI) significantly reduces ischaemic burden. Myocardial blood flow and coronary flow reserve improve regardless of initial defect size after successful CTO PCI.

Area of Science:

  • Cardiovascular Imaging
  • Interventional Cardiology
  • Myocardial Perfusion Imaging

Background:

  • Chronic total occlusion (CTO) poses challenges in coronary artery disease management.
  • Assessing the impact of CTO percutaneous coronary intervention (PCI) on myocardial perfusion is crucial for treatment efficacy.
  • Understanding the relationship between ischaemic burden and perfusion changes post-CTO PCI is vital.

Purpose of the Study:

  • To investigate the correlation between ischaemic burden and myocardial perfusion changes after successful CTO PCI.
  • To quantify the impact of CTO PCI on perfusion defect size, myocardial blood flow (MBF), and coronary flow reserve (CFR).

Main Methods:

  • 193 patients with CTO underwent [15O]H2O Positron Emission Tomography (PET) before and 3 months after CTO PCI.
  • Perfusion defect size, hyperaemic MBF, and CFR were assessed and compared based on baseline defect size (limited, moderate, large).
  • Patients were stratified into tertiles based on baseline hyperaemic MBF and CFR to analyze changes post-intervention.

Main Results:

  • Significant reductions in perfusion defect size were observed, with greater reduction in patients with larger baseline defects (p<0.01).
  • Hyperaemic MBF and CFR improved significantly across all baseline defect sizes (p=0.45 and p=0.55, respectively).
  • Post-CTO PCI changes in hyperaemic MBF and CFR were comparable across baseline tertiles (p=0.75 and p=0.79, respectively).

Conclusions:

  • CTO PCI effectively reduces ischaemic burden, particularly in patients with larger initial perfusion defects.
  • Significant improvements in myocardial blood flow and coronary flow reserve are achieved irrespective of baseline perfusion defect size or absolute flow values.
  • These findings highlight the benefit of CTO PCI in restoring myocardial perfusion across a spectrum of ischaemic severity.
Abstract